Impact of a gluten-free diet on bone mineral density in celiac XXXX .

@entity1 @entity3604 @entity1593 @entity174 @entity170 @entity2331 @entity460 @entity6092 @entity560
BACKGROUND: @entity170 ( @entity170 ) is a metabolic bone illness that may complicate @entity1593 ( @entity1593 ). It can lead to devastating consequences because of low bone mass and @entity174 . PURPOSE: To study the @entity170 prevalence in a group of Brazilian @entity1 with @entity1593 and the value of a @entity1593 ( @entity1593 ). METHODS: Retrospective study of celiac female @entity1 from a single University Center followed with bone densitometries. Results from densitometry made at first visit were compared with a second study after a median time of 5 years. During this period, @entity1 were submitted to a @entity1593 according to orientations from special program training. @entity460 and @entity560 were prescribed to those @entity1 who did not reach the minimal daily requirement through diet. RESULTS: Forty-one celiac female @entity1 , mean age 46.1    14.8 years, were included. The prevalence of @entity2331 at first visit was 56.1% and that of @entity170 29.2%. @entity170 was associated with longer disease duration (p = 0.01). The second densitometry was performed in a median time of 5 years (range 1 to 13 years) and disclosed 58.9% @entity2331 and 28.2% @entity170 . The @entity1593 improved bone mass, mainly at (of) spine (comparison of T score with p = 0.03 and of bone mass in g/cm2 with p = 0.02), but it was not sufficient to reduce the number of @entity6092 (p = 0.9) and @entity3604 @entity1 (p = 0.4). During the follow up period 25% of @entity3604 @entity1 developed low impact @entity174 . CONCLUSION: Bone health is notably impaired at baseline in @entity1593 @entity1 , especially in those with a diagnostic delay. A @entity1593 modestly improved bone mass density with low impact @entity174 occurring in one third of @entity1 during the follow up period.
